Home / Compliance actions / 652067

FDA Warning Letter — Intas Pharmaceuticals Limited

Case 652067 — FEI 3004011473

The FDA took a Warning Letter action against Intas Pharmaceuticals Limited on July 28, 2023 (Taluka Sanand, Ahmedabad, India). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
Intas Pharmaceuticals Limited
Date
July 28, 2023
Fiscal Year
2023
Product Type
Drugs
Center
CDER
Location
Taluka Sanand, Ahmedabad (India)

Facility

Recent inspections

  • 1191818 (OAI Fri Dec 02 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1119170 (VAI Fri Feb 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1092798 (VAI Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 992746 (VAI Wed Oct 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 910188 (NAI Fri Dec 19 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources